aTYR PHARMA INC (ATYR) Capital expenditures 2016–2025
aTYR PHARMA INC (ATYR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$77,000FY2025 · since FY2016: $600,000 → $77,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $77,000 | +18.5% |
| FY2024 | $65,000 | -98.5% |
| FY2023 | $4.2M | +156.9% |
| FY2022 | $1.6M | +754.7% |
| FY2021 | $192,000 | -5.0% |
| FY2020 | $202,000 | +155.7% |
| FY2019 | $79,000 | -86.7% |
| FY2018 | $594,000 | -54.7% |
| FY2017 | $1.3M | +118.7% |
| FY2016 | $600,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice